Literature DB >> 23196000

Adult with cerebellar anaplastic pilocytic astrocytoma associated with BRAF V600E mutation and p16 loss.

Yee Hui Yeo1, Nicholas P Byrne, George J Counelis, Arie Perry.   

Abstract

Pilocytic astrocytoma (PA) is the most common pediatric tumor, with the vast majority being benign (WHO Grade I). Herein, we present a rare sporadic (not radiation- or NF1-associated) anaplastic PA arising from the cerebellum of an adult patient. The diagnosis was based on the coexistence of classic PA and more cellular foci, associated with both tumor necrosis and up to 27 mitoses per 10 high power fields. Based on these features, the tumor was felt to be equivalent in biological behavior to that of a WHO Grade III astrocytoma. Additional genetic studies revealed the presence of a BRAF V600E mutation. In comparison to the foci of classic PA, the malignant component showed increased p53 protein expression, decreased p16 protein expression, and hemizygous p16 gene deletion by FISH analysis. This case provides additional support for the concept of anaplastic transformation in PA and further elucidates the possible molecular pathways associated with malignant progression.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23196000     DOI: 10.5414/NP300564

Source DB:  PubMed          Journal:  Clin Neuropathol        ISSN: 0722-5091            Impact factor:   1.368


  9 in total

Review 1.  Review of low-grade gliomas in children--evolving molecular era and therapeutic insights.

Authors:  Soumen Khatua; Jason Wang; Veena Rajaram
Journal:  Childs Nerv Syst       Date:  2015-02-27       Impact factor: 1.475

2.  Adult pilocytic astrocytomas: clinical features and molecular analysis.

Authors:  Brett J Theeler; Benjamin Ellezam; Zsila S Sadighi; Vidya Mehta; M Diep Tran; Adekunle M Adesina; Janet M Bruner; Vinay K Puduvalli
Journal:  Neuro Oncol       Date:  2014-01-26       Impact factor: 12.300

3.  CDKN2A/B Loss Is Associated with Anaplastic Transformation in a Case of NTRK2 Fusion-positive Pilocytic Astrocytoma.

Authors:  G Y López; A Perry; B Harding; M Li; M Santi
Journal:  Neuropathol Appl Neurobiol       Date:  2018-06-21       Impact factor: 8.090

4.  Pilomyxoid Astrocytoma (PMA) Shows Significant Differences in Gene Expression vs. Pilocytic Astrocytoma (PA) and Variable Tendency Toward Maturation to PA.

Authors:  Bette K Kleinschmidt-DeMasters; Andrew M Donson; Hannes Vogel; Nicholas K Foreman
Journal:  Brain Pathol       Date:  2015-01-27       Impact factor: 6.508

Review 5.  Pediatric low-grade gliomas: how modern biology reshapes the clinical field.

Authors:  Guillaume Bergthold; Pratiti Bandopadhayay; Wenya Linda Bi; Lori Ramkissoon; Charles Stiles; Rosalind A Segal; Rameen Beroukhim; Keith L Ligon; Jacques Grill; Mark W Kieran
Journal:  Biochim Biophys Acta       Date:  2014-02-28

6.  Recent Progress in the Pathology and Genetics of Pilocytic and Pilomyxoid Astrocytomas

Authors:  Cristine Ding; Tarik Tihan
Journal:  Balkan Med J       Date:  2018-07-09       Impact factor: 2.021

7.  Adult pilocytic astrocytoma in the molecular era: a comprehensive review.

Authors:  Timothy A Gregory; Lyndon B Chumbley; John W Henson; Brett J Theeler
Journal:  CNS Oncol       Date:  2021-01-15

8.  FGFR1 tyrosine kinase domain duplication in pilocytic astrocytoma with anaplasia.

Authors:  Leomar Y Ballester; Marta Penas-Prado; Norman E Leeds; Jason T Huse; Gregory N Fuller
Journal:  Cold Spring Harb Mol Case Stud       Date:  2018-04-02

9.  Characterizing temporal genomic heterogeneity in pediatric low-grade gliomas.

Authors:  Margot A Lazow; Lindsey Hoffman; Austin Schafer; Diana S Osorio; Daniel R Boué; Sarah Rush; Erin Wright; Adam Lane; Mariko D DeWire-Schottmiller; Teresa Smolarek; Jared Sipple; Heather Taggert; Jaime Reuss; Ralph Salloum; Trent R Hummel; Peter de Blank; Natasha Pillay-Smiley; Mary E Sutton; Anthony Asher; Charles B Stevenson; Rachid Drissi; Jonathan L Finlay; Maryam Fouladi; Christine Fuller
Journal:  Acta Neuropathol Commun       Date:  2020-11-05       Impact factor: 7.801

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.